Latest Breaking News On - Heart transplant department - Page 2 : comparemela.com

Alnylam Presents Additional Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with Cardiomyopathy at Heart Failure Society of America Annual Meeting

30.09.2022 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from exploratory endpoints and additional analyses of prespecified patient subgroups for the primary and secondary endpoints in the APOLLO-B . Seite 1

Parag kaleAlnylam pharmaceuticals incAlnylam pharmaceuticalsHeart failure societyAnnual scientific meetingInternational symposiumStaff cardiologistHeart transplant departmentBaylor university medical

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesChristine regan lindenboomParag kaleJosh brodskyRenan denoncourtYork heart associationFranchise lead at alnylam pharmaceuticalsDrug administrationAlnylam pharmaceuticals incHealth statusExchange commissionAlnylam pharmaceuticalsEuropean unionNew data further support potentialEffective treatment